Get the latest Science News and Discoveries
The Ottawa Hospital is expanding life-saving biotherapeutics research and manufacturing to its new campus thanks to ... - EurekAlert
The Ottawa Hospital is receiving $59 million to boost Canada’s capacity to develop and manufacture life-saving biotherapeutics, including vaccines, gene therapies and cell therapies. Most of the funding ($47 million) will support the construction and operation of a world-class biomanufacturing facility at The Ottawa Hospital’s new campus, while the remainder will enable harmonization and cooperation across six Canadian biomanufacturing facilities.
None
Or read this on Eureka Alert